TAIHO ONCOLOGY: TO SUBMIT NDA TO U.S. FDA SEEKING APPROVAL OF AZACITIDINE & CEDAZURIDINE AS ORAL TREATMENT REGIMEN FOR ADULTS WITH MDS OR CMML

Reuters · 3d ago

Please log in to view news